Sign In
Buy LIVN
$71.33
-2.00 (-2.73%)
At Close: Jun 03, 2026
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
10:00am, Thursday, 21'st May 2026
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Stefano Folli will join the Company as incoming President, Cardi
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
09:15am, Thursday, 21'st May 2026
LONDON--(BUSINESS WIRE)---- $LIVN #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Stefano Folli will join the Company as incoming Presid
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June
08:00am, Tuesday, 19'th May 2026
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the Goldman Sachs 47th Annual Global Healthcare Con
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know
01:01pm, Monday, 11'th May 2026
LivaNova (LIVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript
05:01pm, Wednesday, 06'th May 2026
LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
08:26am, Wednesday, 06'th May 2026
LivaNova (LIVN) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.88 per share a year ago.
LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
06:00am, Wednesday, 06'th May 2026
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2026 and raised full-year
Annals of Internal Medicine Publishes 12-Month Results from LivaNova's OSPREY Clinical Study for Obstructive Sleep Apnea
05:05pm, Monday, 20'th Apr 2026
LONDON--(BUSINESS WIRE)---- $LIVN #livn--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Annals of Internal Medicine has published an article
Aberdeen Group plc Lowers Stock Holdings in LivaNova PLC $LIVN
03:08am, Friday, 10'th Apr 2026
Aberdeen Group plc trimmed its position in shares of LivaNova PLC (NASDAQ: LIVN) by 89.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
SG Americas Securities LLC Buys 11,066 Shares of LivaNova PLC $LIVN
05:06am, Tuesday, 07'th Apr 2026
SG Americas Securities LLC raised its stake in shares of LivaNova PLC (NASDAQ: LIVN) by 83.9% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
Allspring Global Investments Holdings LLC Reduces Stake in LivaNova PLC $LIVN
03:25am, Monday, 06'th Apr 2026
Allspring Global Investments Holdings LLC lessened its holdings in shares of LivaNova PLC (NASDAQ: LIVN) by 8.9% during the undefined quarter, according to its most recent 13F filing with the SEC. The
Exchange Traded Concepts LLC Buys New Shares in LivaNova PLC $LIVN
03:52am, Saturday, 04'th Apr 2026
Exchange Traded Concepts LLC purchased a new position in shares of LivaNova PLC (NASDAQ: LIVN) in the undefined quarter, according to the company in its most recent disclosure with the Securities and
LivaNova Expands OSA Care With FDA-Approved aura6000 System
12:22pm, Wednesday, 25'th Mar 2026
LIVN wins FDA nod for its aura6000 sleep apnea system, marking a pivotal step in neurostimulation with strong trial results and new growth potential.
LivaNova to Announce First-Quarter 2026 Results
09:00am, Wednesday, 25'th Mar 2026
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2026 results on Wed., May 6,
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of “Moderate Buy” from Brokerages
02:40am, Monday, 23'rd Mar 2026
LivaNova PLC (NASDAQ: LIVN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten ratings firms that are presently covering the stock, Marketbeat Ratings reports. On
